DHQP Global NOFO

The DHQP Global Notice of Funding Opportunity is a forecasted federal grant initiative issued by the Centers for Disease Control and Prevention under the U.S. Department of Health and Human Services. The program is administered through the National Center for Emerging and Zoonotic Infectious Diseases and is designed to support global public health efforts focused on antimicrobial resistance, healthcare associated infections, and emerging infectious disease threats. This initiative builds on existing CDC global health infrastructure, including laboratory and surveillance networks, and reflects a continued federal commitment to strengthening international health security systems. The primary purpose of this funding opportunity is to support a hybrid model that combines non research implementation activities with targeted research. The program emphasizes strengthening detection, surveillance, prevention, and response systems across healthcare, community, and environmental settings in low and middle income countries. Activities are expected to reduce illness and mortality associated with antimicrobial resistance and healthcare associated infections while also improving infection prevention and control practices and antimicrobial stewardship. The initiative also seeks to protect healthcare workers and patients while reducing overall healthcare costs through improved system efficiency. Funding under this opportunity is expected to be distributed through cooperative agreements, indicating substantial involvement by the CDC in program implementation and oversight. The total estimated program funding is sixty million dollars with approximately thirty awards anticipated. While specific award floor and ceiling values are not defined in the forecast, the funding is expected to support a range of project sizes aligned with the program’s global scope and complexity. There is no cost sharing or matching requirement, making the program more accessible to a wide range of eligible entities. Eligibility for this opportunity is broad and inclusive, allowing participation from state and local governments, nonprofit organizations with and without federal tax exempt status, institutions of higher education, tribal governments and organizations, for profit entities, and small businesses. The notice explicitly states that it is open to any type of entity, reinforcing its global and inclusive intent. This wide eligibility scope aligns with the program’s objective of building collaborative international networks and leveraging diverse organizational expertise to address complex global health challenges. The application process is expected to follow standard federal grant submission procedures through electronic systems, with applications required to be submitted by the specified deadline. Although detailed application components are not yet provided in the forecast, applicants can anticipate requirements typical of CDC cooperative agreements, including technical proposals, work plans, budgets, and organizational capacity documentation. Evaluation criteria are likely to focus on technical merit, feasibility, organizational experience, and alignment with CDC priorities in antimicrobial resistance and infectious disease control. The timeline indicates that the opportunity is currently in a forecast stage, with an estimated posting date in March of the following year and an application deadline in May. Awards are expected to be announced by late August, with project activities beginning at the end of September. The forecast does not explicitly state whether the opportunity is recurring, but similar CDC funding initiatives are often released on a periodic basis. Contact information is provided through a CDC program email and a listed point of contact, allowing prospective applicants to seek clarification as additional details become available.